Home › Celgene's Revlimid improves survival in blood cancer patients
 

Keywords :   


Celgene's Revlimid improves survival in blood cancer patients

2013-07-12 07:30:47| Biotech - Topix.net

Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in blood cancer patients.

Tags: blood cancer patients survival

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »